Ion Beam Applications Dirección

Dirección controles de criterios 4/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Olivier Legrain

Chief Executive Officer (CEO)

€880.0k

Compensación total

Porcentaje del salario del CEO	46.8%
Permanencia del CEO	12yrs
Participación del CEO	n/a
Permanencia media de la dirección	12yrs
Promedio de permanencia en la Junta Directiva	10.5yrs

Actualizaciones recientes de la dirección

Here's Why Shareholders May Want To Be Cautious With Increasing Ion Beam Applications SA's (EBR:IBAB) CEO Pay Packet

Jun 01

Recent updates

Further Upside For Ion Beam Applications SA (EBR:IBAB) Shares Could Introduce Price Risks After 29% Bounce

Mar 25

Is Ion Beam Applications (EBR:IBAB) Using Too Much Debt?

Nov 07

Ion Beam Applications (EBR:IBAB) Has Some Way To Go To Become A Multi-Bagger

Oct 05

Ion Beam Applications (EBR:IBAB) Is Investing Its Capital With Increasing Efficiency

Jan 31

Is Ion Beam Applications (EBR:IBAB) A Risky Investment?

Sep 28

Here's Why Shareholders May Want To Be Cautious With Increasing Ion Beam Applications SA's (EBR:IBAB) CEO Pay Packet

Jun 01

Ion Beam Applications' (EBR:IBAB) Returns On Capital Are Heading Higher

May 29

Does Ion Beam Applications SA (EBR:IBAB) Have A Place In Your Dividend Stock Portfolio?

Apr 20

Is Ion Beam Applications (EBR:IBAB) A Risky Investment?

Mar 30

Should You Use Ion Beam Applications' (EBR:IBAB) Statutory Earnings To Analyse It?

Feb 10

What Type Of Shareholders Make Up Ion Beam Applications SA's (EBR:IBAB) Share Registry?

Jan 06

Does This Valuation Of Ion Beam Applications SA (EBR:IBAB) Imply Investors Are Overpaying?

Dec 10

Ion Beam Applications' (EBR:IBAB) Shareholders Are Down 64% On Their Shares

Nov 17

Ion Beam Applications SA (EBR:IBAB) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

Aug 20

Estimating The Intrinsic Value Of Ion Beam Applications SA (EBR:IBAB)

Jul 21

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Olivier Legrain en comparación con los beneficios de Ion Beam Applications?
Fecha	Compensación total	Salario	Ingresos de la empresa
Dec 31 2023	n/a	n/a	-€9m
Sep 30 2023	n/a	n/a	-€14m
Jun 30 2023	n/a	n/a	-€19m
Mar 31 2023	n/a	n/a	-€7m
Dec 31 2022	€880k	€412k	€6m
Sep 30 2022	n/a	n/a	€5m
Jun 30 2022	n/a	n/a	€4m
Mar 31 2022	n/a	n/a	€4m
Dec 31 2021	€885k	€391k	€4m
Sep 30 2021	n/a	n/a	€23m
Jun 30 2021	n/a	n/a	€42m
Mar 31 2021	n/a	n/a	€37m
Dec 31 2020	€768k	€389k	€32m
Sep 30 2020	n/a	n/a	€16m
Jun 30 2020	n/a	n/a	€884k
Mar 31 2020	n/a	n/a	€4m
Dec 31 2019	€575k	€386k	€8m
Sep 30 2019	n/a	n/a	€5m
Jun 30 2019	n/a	n/a	-€2m
Mar 31 2019	n/a	n/a	-€3m
Jan 01 2019	n/a	n/a	-€4m
Sep 30 2018	n/a	n/a	-€25m
Jun 30 2018	n/a	n/a	-€45m
Mar 31 2018	n/a	n/a	-€43m
Dec 31 2017	€758k	€371k	-€42m

Compensación vs. Mercado: La compensación total ($USD943.70K) de Olivier está en línea con el promedio de empresas de tamaño similar en el mercado Belgian ($USD792.61K).

Compensación vs. Ingresos: La compensación de Olivier ha sido consistente con los resultados de la empresa en el último año.

CEO

Olivier Legrain (55 yo)

12yrs

Permanencia

€880,004

Compensación

Mr. Olivier Legrain has been the Chief Executive Officer, President and Executive Director at Ion Beam Applications, S.A. since May 9, 2012 and served as its President of Molecular Medicine at Ion Beam App...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Pierre Mottet	Chairman of The Board	26yrs	€52.50k	sin datos
Olivier Legrain	CEO, President	12yrs	€880.00k	sin datos
Yves Jongen	Founder	no data	€576.92k	sin datos
Soumya Chandramouli	Chief Financial Officer	7.9yrs	sin datos	sin datos
Frederic Nolf	Chief Human Resources & Sustainability Officer	14.3yrs	sin datos	sin datos
Marc Van der Burght	Chief Operation Officer	no data	sin datos	sin datos
Olivier Lechien	Corporate Communication Director	no data	sin datos	sin datos
Thomas Canon	Sustainability Program Director	no data	sin datos	sin datos
Bruno Scutnaire	President of IBA RadioPharma Solutions	no data	sin datos	sin datos

12.0yrs

Permanencia media

55yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de IBAB es experimentado (11.9 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Pierre Mottet	Chairman of The Board	26yrs	€52.50k	sin datos
Olivier Legrain	CEO, President	12yrs	€880.00k	sin datos
Yves Jongen	Founder	33yrs	€576.92k	sin datos
Marcel Miller	Independent Director	13yrs	€34.00k	sin datos
Richard Hausmann	Independent Director	3.8yrs	€32.40k	sin datos
Sybille van den Hove	Independent Director	9yrs	€25.60k	sin datos
Hedvig Hricak	Independent Director	7yrs	€27.20k	sin datos
Christine Dubus	Independent Director	3.8yrs	€39.40k	sin datos

10.5yrs

Permanencia media

63yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de IBAB son experimentados ( 10.4 años antigüedad media).

Ion Beam Applications Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

Ion Beam Applications SA, Annual General Meeting, Jun 12, 2024

Insufficient new directors

Here's Why Shareholders May Want To Be Cautious With Increasing Ion Beam Applications SA's (EBR:IBAB) CEO Pay Packet

Recent updates

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Further Upside For Ion Beam Applications SA (EBR:IBAB) Shares Could Introduce Price Risks After 29% Bounce

Full year 2023 earnings released

Ion Beam Applications SA to Report First Half, 2024 Results on Aug 29, 2024

Ion Beam Applications S.A., CMI Inc. and Life Molecular Imaging Announce Japanese Approval for the Reimbursement of Amyloid-Pet Diagnostic Neuraceq in Alzheimer's Disease

Consensus EPS estimates fall by 20%

Ion Beam Applications SA, Annual General Meeting, Jun 12, 2024

Is Ion Beam Applications (EBR:IBAB) Using Too Much Debt?

New minor risk - Share price stability

Ion Beam Applications S.A Plans Total System Restoration on its First-Ever Proton Therapy Installation

Price target decreased by 18% to €18.00

Insufficient new directors

Price target increased by 26% to €22.30

Full year 2022 earnings released

Ion Beam Applications SA to Report Q1, 2023 Results on May 18, 2023

Price target increased to €19.25

Ion Beam Applications (EBR:IBAB) Has Some Way To Go To Become A Multi-Bagger

First half 2022 earnings released: €0.059 loss per share (vs €0.066 loss in 1H 2021)

Ion Beam Applications SA Continues to Shape the Future of Proton Therapy At Estro 2022 Annual Congress

Ion Beam Applications SA (ENXTBR:IBAB) acquired Modus Medical Devices Inc.

Full year 2021 earnings: EPS exceeds analyst expectations

Price target increased to €17.75

Investor sentiment improved over the past week

Ion Beam Applications (EBR:IBAB) Is Investing Its Capital With Increasing Efficiency

IBA Launches Compact Low-Energy Cyclotron, Cyclone® KEY

First half 2021 earnings released: €0.066 loss per share (vs €0.41 loss in 1H 2020)

First half 2021 earnings released: €0.066 loss per share (vs €0.41 loss in 1H 2020)

First half 2021 earnings released: €0.066 loss per share (vs €0.41 loss in 1H 2020)

Is Ion Beam Applications (EBR:IBAB) A Risky Investment?

First half 2021 earnings released

Ion Beam Applications S.A. Announces Launch of a Large-Scale, Multi-Institutional, Randomized Controlled Clinical Trial

Price target increased to €15.00

Here's Why Shareholders May Want To Be Cautious With Increasing Ion Beam Applications SA's (EBR:IBAB) CEO Pay Packet

Ion Beam Applications' (EBR:IBAB) Returns On Capital Are Heading Higher

Does Ion Beam Applications SA (EBR:IBAB) Have A Place In Your Dividend Stock Portfolio?

Is Ion Beam Applications (EBR:IBAB) A Risky Investment?

Full year 2020 earnings released

IBA (Ion Beam Applications S.A. and NorthStar Medical Radioisotopes Expand Collaboration to Enable Global Availability of Diagnostic Radioisotope Technetium-99m (Tc-99m)

Ion Beam Applications SA Receives Down Payment from National Cancer Center Korea for A Second Proteus® System

Should You Use Ion Beam Applications' (EBR:IBAB) Statutory Earnings To Analyse It?

Price target raised to €12.60

Ion Beam Applications SA to Report Q3, 2021 Results on Nov 18, 2021

New 90-day high: €13.46

What Type Of Shareholders Make Up Ion Beam Applications SA's (EBR:IBAB) Share Registry?

Does This Valuation Of Ion Beam Applications SA (EBR:IBAB) Imply Investors Are Overpaying?

Ion Beam Applications' (EBR:IBAB) Shareholders Are Down 64% On Their Shares

New 90-day high: €11.96

New 90-day high: €11.68

Ion Beam Applications SA Signs Contract for the First End-To-End Rhodotron® Duo Solution for Multi-Purpose Irradiation in Taiwan

Ion Beam Applications SA Announces First Payment of EUR 20 Million Received for Strategic Licensing Deal in China

New 90-day high: €10.60

Ion Beam Applications SA to Report Fiscal Year 2020 Results on Mar 25, 2021

New 90-day low - €7.14

Ion Beam Applications SA (EBR:IBAB) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock?

New 90-day low - €7.30

Estimating The Intrinsic Value Of Ion Beam Applications SA (EBR:IBAB)

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad